CoChat

Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring

Open access
de Viron, Sylviane, Trotta, Laura, Schumacher, Helmut, Lomp, Hans-Juergen, Höppner, Sebastiaan, Young, Steve, Buyse, Marc · 2022 · Therapeutic Innovation & Regulatory Science

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.

Abstract

Background: A central statistical assessment of the quality of data collected in clinical trials can improve the quality and efficiency of sponsor oversight of clinical investigations. Material and Methods: The database of a large randomized clinical trial with known fraud was reanalyzed with a view to identifying, using only statistical monitoring techniques, the center where fraud had been confirmed. The analysis was conducted with an unsupervised statistical monitoring software using mixed-effects statistical models. The statistical analyst was unaware of the location, nature, and extent of the fraud. Results: Five centers were detected as atypical, including the center with known fraud (which was ranked 2). An incremental analysis showed that the center with known fraud could have been detected after only 25% of its data had been reported. Conclusion: An unsupervised approach to central monitoring, using mixed-effects statistical models, is effective at detecting centers with fraud or other data anomalies in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s43441-021-00341-5

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Detection strategy. For DQA re-runs of earlier versions of full study database, the cut-off calendar dates were determined by successive 5% lowering of the data volume for center #2013
Fig. 1 Detection strategy. For DQA re-runs of earlier versions of full study database, the cut-off calendar dates were determined by successive 5% lowering of the data volume for center #2013CC BY · PubMed Central
Fig. 2 Bubble plot using full study database showing 5 centers with a Data Inconsistency Score (DIS) > 1.3 (P-value < 0.05). Center with known fraud is denoted B (Center #2013)
Fig. 2 Bubble plot using full study database showing 5 centers with a Data Inconsistency Score (DIS) > 1.3 (P-value < 0.05). Center with known fraud is denoted B (Center #2013)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 1

  1. Evans S. Statistical aspects of the detection of fraud. In: Fraud and misconduct in medical research, 3rd edn. BMJ Publishing Group, London; 2001. pp. 186–204.

Cited by

See all 21

Metadata

Authors
de Viron, S., Trotta, L., Schumacher, H., Lomp, H.-J., Höppner, S., Young, S., & Buyse, M.
Affiliations
  • Boehringer Ingelheim (Germany) (DE)
  • International Drug Development Institute (Belgium) (BE)
Venue
Therapeutic Innovation & Regulatory Science
Published
2021-09-29
Volume
56
Issue
1
Pages
130-136
ISSN
  • 2168-4790 (ISSN-L)
  • 2168-4804
OpenAlex
W3203182584
Cited by
16
References
23
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 2
FWCI
1.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Therapeutic Innovation & Regulatory Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Document Server@UHasselt (UHasselt) (submittedVersion, cc-by)
Funders
  • Boehringer Ingelheim
  • CluePoints
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Benford’s Law and Fraud Detection
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Education › Academic integrity and plagiarism
Keywords
mixed models, data anomalies, randomized controlled trials, incremental analysis, data quality
MeSH terms
Fraud, Models, Statistical, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring. https://app.cochat.ai/papers/10.1007/s43441-021-00341-5
The paper
de Viron, S., Trotta, L., Schumacher, H., Lomp, H.-J., Höppner, S., Young, S., & Buyse, M. (2022). Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-021-00341-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.